Heat Biologics blows up on positive cancer therapy data. Thirteen stocks gained ground with 12 losing and two flat. Thanks to the out-sized gain by Heat Biologics, the overall average was a gain of 1.6%.
IBio and Adaptive picked up 6% while VBI picked up 5%.
On the downside, Inovio fell 8%, Altimmune fell 7% and Vaxart fell 6%.
No comments:
Post a Comment